Literature DB >> 27685633

Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.

Zuozhang Yang1, Xiaojuan Li1, Yihao Yang1, Zewei He1, Xin Qu1, Ya Zhang1.   

Abstract

Long noncoding RNAs (lncRNAs) are a class of non-protein-coding molecules longer than 200 nucleotides that are involved in the development and progression of many types of tumors. Numerous lncRNAs regulate cell proliferation, metastasis, and chemotherapeutic drug resistance. Osteosarcoma is one of the main bone tumor subtypes that poses a serious threat to adolescent health. We summarized how lncRNAs regulate osteosarcoma progression, invasion, and drug resistance, as well as how lncRNAs can function as biomarkers or independent prognostic indicators with respect to osteosarcoma therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27685633      PMCID: PMC5059871          DOI: 10.1038/cddis.2016.272

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  121 in total

1.  P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway.

Authors:  Ruipeng Song; Ke Tian; Weidong Wang; Limin Wang
Journal:  Int J Surg       Date:  2015-04-30       Impact factor: 6.071

Review 2.  Role of micro-RNA (miRNA) in pathogenesis of glioblastoma.

Authors:  J W Luo; X Wang; Y Yang; Q Mao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

3.  Targeting osteosarcoma.

Authors:  Darien E Reed; Kevan M Shokat
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 4.  The history and future of targeting cyclin-dependent kinases in cancer therapy.

Authors:  Uzma Asghar; Agnieszka K Witkiewicz; Nicholas C Turner; Erik S Knudsen
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694

Review 5.  The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.

Authors:  Tanja Kunej; Jana Obsteter; Ziva Pogacar; Simon Horvat; George Adrian Calin
Journal:  Crit Rev Clin Lab Sci       Date:  2014-08-15       Impact factor: 6.250

6.  Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.

Authors:  Liang Bo Zhu; Jian Jiang; Xiao Ping Zhu; Tao Fang Wang; Xuan Yin Chen; Qin Feng Luo; Yong Shu; Zhi Li Liu; Shan Hu Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 7.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

8.  Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling.

Authors:  Sara R Martins-Neves; Daniela I Paiva-Oliveira; Pauline M Wijers-Koster; Antero J Abrunhosa; Carlos Fontes-Ribeiro; Judith V M G Bovée; Anne-Marie Cleton-Jansen; Célia M F Gomes
Journal:  Cancer Lett       Date:  2015-11-11       Impact factor: 8.679

9.  Telangiectatic osteosarcoma: a review of literature.

Authors:  Jun-Jian Liu; Shen Liu; Jian-Guang Wang; Wei Zhu; Ying-Qi Hua; Wei Sun; Zheng-Dong Cai
Journal:  Onco Targets Ther       Date:  2013-05-28       Impact factor: 4.147

10.  A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.

Authors:  Yongcheng Wang; Jie Yao; Haoye Meng; Zhiguo Yu; Zhigang Wang; Xueling Yuan; Hong Chen; Aiyuan Wang
Journal:  Mol Med Rep       Date:  2014-12-01       Impact factor: 2.952

View more
  50 in total

1.  Measuring lncRNA Expression by Real-Time PCR.

Authors:  Sonam Dhamija; Manoj B Menon
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

3.  MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1.

Authors:  Weichao Li; Zengdong Meng; Tiannan Zou; Gang Wang; Yijing Su; Shaoping Yao; Xianrun Sun
Journal:  Pathol Oncol Res       Date:  2018-12-06       Impact factor: 3.201

4.  Long non-coding RNA AK093407 promotes proliferation and inhibits apoptosis of human osteosarcoma cells via STAT3 activation.

Authors:  Yongkun Wang; Tingting Liang; Yao Wang; Yan Huang; Ye Li
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 5.  Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.

Authors:  Giulia Brisotto; Roberto Guerrieri; Francesca Colizzi; Agostino Steffan; Barbara Montico; Elisabetta Fratta
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Tumor immune microenvironment lncRNAs.

Authors:  Eun-Gyeong Park; Sung-Jin Pyo; Youxi Cui; Sang-Ho Yoon; Jin-Wu Nam
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

7.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

8.  The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.

Authors:  Bo Chen; Qinhua Li; Yongping Zhou; Xujing Wang; Qiqi Zhang; Yongkun Wang; Huiren Zhuang; Xiaohua Jiang; Wujun Xiong
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

9.  Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma.

Authors:  Weifeng Hong; Weicong Zhang; Renguo Guan; Yuying Liang; Shixiong Hu; Yayun Ji; Mouyuan Liu; Hai Lu; Min Yu; Liheng Ma
Journal:  Ann Transl Med       Date:  2019-10

10.  Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.

Authors:  Zheng Ren; Chenyang Li; Yuling Gan; Xiuxin Liu; Fudong Liang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.